Premature cell senescence promotes vascular smooth muscle cell phenotypic modulation and resistance to re-differentiation
Open Access
- 10 June 2025
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 121 (9) , 1448-1463
Abstract
Aims: Human atherosclerotic plaque cells display DNA damage that if left unrepaired can promote premature cell senescence. Vascular smooth muscle cells (VSMCs) predisposed to senescence promote atherogenesis and features of unstable plaques and increase neointima formation after injury. However, how premature VSMC senescence promotes vascular disease and its effects on VSMC phenotype are unknown. Methods and results: Bulk RNA-seq of primary human VSMCs identified 126 significantly up- or down-regulated genes after both DNA damage-induced (D + R) or replicative senescence (RS). Up-regulated genes included senescence markers CDKN2A (p16) and ICAM1 and genes expressed by phenotypically modulated de-differentiated/’fibromyocytic’ VSMCs [osteoprotegerin (TNFRSF11B), fibromodulin (FMOD)] as well as transmembrane protein 178B (TMEM178B) and secreted frizzle-related protein 4 (SFRP4). Mouse VSMCs also up-regulated genes associated with de-differentiated VSMC phenotype, Tmem178b and Sfrp4 after D + R. Single-cell RNA-sequencing of lineage-traced VSMCs in mouse plaques or human plaques showed that VSMCs expressing Cdkn2a had lower contractile marker expression and higher expression of de-differentiated VSMC markers. Mice expressing a VSMC-restricted mutant telomere protein (TRF2T188A) that induces premature senescence showed increased atherosclerosis, expression of multiple de-differentiation genes in plaques and after injury, and differential regulation of pathways associated with extracellular matrix organization, inflammation and Transforming Growth Factor-β (Tgfb). Trf2T188A VSMCs were more resistant to re-differentiation and had dysregulated Tgfb signalling at multiple levels with down-regulated ligands, receptors, and coactivators and up-regulated co-repressor expression. Trf2T188A VSMCs also showed cytosolic DNA and activation of the STING–TBK1–IRF3 pathway that suppressed Tgfb signalling. Silencing IRF3 restored expression of Tgfb pathway components and VSMC contractile markers after TGFb administration. Conclusion: DNA damage and senescence induce genes associated with de-differentiated/fibromyocytic VSMCs, and persistence of these cells in vivo. Failure of senescent VSMCs to re-express contractile markers during re-differentiation suggests that VSMC senescence may promote atherosclerosis and neointima formation in part by inhibiting their re-differentiation.Keywords
Funding Information
- British Heart Foundation (RG71070, RG8455)
- BHF Centres for Research Excellence (RE/18/1/34212, RE/24/130011)
- Regenerative Medicine (RM/13/3/30159)
- National Institute of Health Research Cambridge Biomedical Research Centre
This publication has 49 references indexed in Scilit:
- Developing transcriptomic signatures as a biomarker of cellular senescenceAgeing Research Reviews, 2024
- Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulatorsCell Metabolism, 2024
- The innate immune sensor STING accelerates neointima formation via NF-κB signaling pathwayInternational Immunopharmacology, 2023
- Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stressEuropean Journal of Pharmacology, 2022
- Cytoplasmic DNA: sources, sensing, and role in aging and diseaseCell, 2021
- Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in MiceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Innate Antiviral Host Defense Attenuates TGF-β Function through IRF3-Mediated Suppression of Smad SignalingMolecular Cell, 2014
- Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcificationExperimental Gerontology, 2009
- Osteoprotegerin, vascular calcification and atherosclerosisAtherosclerosis, 2009
- Activation of Cardiac Gene Expression by Myocardin, a Transcriptional Cofactor for Serum Response FactorCell, 2001